Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Edler

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|April 5, 2012
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosisDaniele Campa, Phillip Müller, Lutz Edler, et al.
BMC Cancer|February 15, 2011
Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trialStephanie E Combs, Daniel Habermehl, Tom Ganten, et al.
Cancer|June 22, 2010
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancerIna Thöm, Birte Andritzky, Gunter Schuch, et al.
Experimental Dermatology|August 13, 2010
Anti-annexin 1 antibodies: a new diagnostic marker in the serum of patients with discoid lupus erythematosusCosima C Kretz, Maria Norpo, Lucie Abeler-Dörner, et al.
Radiation Oncology (London, England)|April 30, 2014
Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocolMatthias Uhl, Lutz Edler, Alexandra D Jensen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA geneDorota Butkiewicz, Odilia Popanda, Angela Risch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2005
Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II studyStephanie E Combs, Sybille Gutwein, Daniela Schulz-Ertner, et al.
Lung Cancer (Amsterdam, Netherlands)|October 25, 2006
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphismsOdilia Popanda, Lutz Edler, Peter Waas, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 3, 2007
Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting?Marc-André Weber, Ralf Kinscherf, Holger Krakowski-Roosen, et al.
BMC Cancer|March 20, 2014
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan techniqueGregor Habl, Gencay Hatiboglu, Lutz Edler, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|April 5, 2012
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosisDaniele Campa, Phillip Müller, Lutz Edler, et al.
BMC Cancer|February 15, 2011
Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trialStephanie E Combs, Daniel Habermehl, Tom Ganten, et al.
Cancer|June 22, 2010
Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancerIna Thöm, Birte Andritzky, Gunter Schuch, et al.
Experimental Dermatology|August 13, 2010
Anti-annexin 1 antibodies: a new diagnostic marker in the serum of patients with discoid lupus erythematosusCosima C Kretz, Maria Norpo, Lucie Abeler-Dörner, et al.
Radiation Oncology (London, England)|April 30, 2014
Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocolMatthias Uhl, Lutz Edler, Alexandra D Jensen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA geneDorota Butkiewicz, Odilia Popanda, Angela Risch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2005
Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II studyStephanie E Combs, Sybille Gutwein, Daniela Schulz-Ertner, et al.
Lung Cancer (Amsterdam, Netherlands)|October 25, 2006
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphismsOdilia Popanda, Lutz Edler, Peter Waas, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 3, 2007
Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting?Marc-André Weber, Ralf Kinscherf, Holger Krakowski-Roosen, et al.
BMC Cancer|March 20, 2014
Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan techniqueGregor Habl, Gencay Hatiboglu, Lutz Edler, et al.
Pageof 13